Javascript must be enabled to continue!
Berberine through PPAR- γ/HO-1 Pathway Regulates Macrophage Polarization
View through CrossRef
Abstract
Objective:
To use ox-LDL and LPS to induce RAW264.7 macrophages to create an inflammation model, and to observe the regulation of berberine on the secretion of inflammatory factors and macrophage polarization in macrophages under inflammatory conditions and the relationship between PPAR-γ/HO-1. The relationship between the pathways provides the basis for berberine in the treatment of atherosclerosis.
Results:
1. Compared with the model group, the iNOS, and IL-6 produced by the berberine group, berberine + ZNPP, and berberine + GW9662 were significantly decreased, (P<0.05); Compared with the berberine + GW9662 group and the berberine + ZNPP group, the secretion of iNOS and IL-6 increased in the berberine group, (P<0.05).
2. Compared with the model group, Arg-1, IL-4, and IL-10 in the Berberine group, berberine + GW9662 and berberine + ZNPP groups increased significantly (P < 0.05); Compared with the berberine group, Arg-1, IL-4 and IL-10 in Berberine + GW9662 and berberine + ZNPP groups were significantly lower than those in Berberine group (P < 0.05).
3. For flow cytometry, CD80 positive cells are used to represent M1 cells, CD163 positive cells represent M2 cells, and the ratio of M2/M1 cells represents the polarization of macrophages, among which the ratio of M2/M1 cells in berberine group Compared with the berberine + ZNPP group and the berberine + GW9662 group, the ratio of M2/M1 in the berberine group was higher, (P<0.05).
4. Western blotting method showed that the protein expression of PPAR-γ in the berberine group, the berberine + GW9662 group, and the berberine + ZNPP group was significantly increased compared with the model group, ( P<0.05); the expression of HO-1 protein in the berberine group, the berberine + GW9662 group, and the berberine + ZNPP group were significantly higher than that in the model group, (P<0.05). The protein expressions of PPAR-γ and HO-1 in the alkali group were higher than those in the berberine + GW9662 and berberine + ZNPP group, (P<0.05).
Conclusion:
Berberine can regulate macrophage polarization through the PPAR-γ/HO-1 pathway, so that macrophages are polarized from M1 macrophages to M2 macrophages, and play an anti-inflammatory and antioxidant role. Berberine provides evidence for its anti-atherosclerotic effect.
Research Square Platform LLC
Title: Berberine through PPAR- γ/HO-1 Pathway Regulates Macrophage Polarization
Description:
Abstract
Objective:
To use ox-LDL and LPS to induce RAW264.
7 macrophages to create an inflammation model, and to observe the regulation of berberine on the secretion of inflammatory factors and macrophage polarization in macrophages under inflammatory conditions and the relationship between PPAR-γ/HO-1.
The relationship between the pathways provides the basis for berberine in the treatment of atherosclerosis.
Results:
1.
Compared with the model group, the iNOS, and IL-6 produced by the berberine group, berberine + ZNPP, and berberine + GW9662 were significantly decreased, (P<0.
05); Compared with the berberine + GW9662 group and the berberine + ZNPP group, the secretion of iNOS and IL-6 increased in the berberine group, (P<0.
05).
2.
Compared with the model group, Arg-1, IL-4, and IL-10 in the Berberine group, berberine + GW9662 and berberine + ZNPP groups increased significantly (P < 0.
05); Compared with the berberine group, Arg-1, IL-4 and IL-10 in Berberine + GW9662 and berberine + ZNPP groups were significantly lower than those in Berberine group (P < 0.
05).
3.
For flow cytometry, CD80 positive cells are used to represent M1 cells, CD163 positive cells represent M2 cells, and the ratio of M2/M1 cells represents the polarization of macrophages, among which the ratio of M2/M1 cells in berberine group Compared with the berberine + ZNPP group and the berberine + GW9662 group, the ratio of M2/M1 in the berberine group was higher, (P<0.
05).
4.
Western blotting method showed that the protein expression of PPAR-γ in the berberine group, the berberine + GW9662 group, and the berberine + ZNPP group was significantly increased compared with the model group, ( P<0.
05); the expression of HO-1 protein in the berberine group, the berberine + GW9662 group, and the berberine + ZNPP group were significantly higher than that in the model group, (P<0.
05).
The protein expressions of PPAR-γ and HO-1 in the alkali group were higher than those in the berberine + GW9662 and berberine + ZNPP group, (P<0.
05).
Conclusion:
Berberine can regulate macrophage polarization through the PPAR-γ/HO-1 pathway, so that macrophages are polarized from M1 macrophages to M2 macrophages, and play an anti-inflammatory and antioxidant role.
Berberine provides evidence for its anti-atherosclerotic effect.
Related Results
Network Pharmacology and Computational Approach to Unveiling the Mechanism of Berberine in Depression
Network Pharmacology and Computational Approach to Unveiling the Mechanism of Berberine in Depression
Introduction:
Depression is a prevalent and often underdiagnosed neuropsychiatric disorder.
Natural herbal medicinal products are receiving more attention as po...
611-P: Berberine Prevented High-Fat Diet-Induced Metabolic Disorders via Inhibition of Whole Lipid Metabolism
611-P: Berberine Prevented High-Fat Diet-Induced Metabolic Disorders via Inhibition of Whole Lipid Metabolism
Berberine, an alkaloid extracted from coptis and phellodendron, is known to alleviate lipid metabolism disorders, but the precise molecular mechanism remains unknown. This study ai...
The role of l-arginine/NO/cGMP/KATP channel pathway in the local antinociceptive effect of berberine in the rat formalin test
The role of l-arginine/NO/cGMP/KATP channel pathway in the local antinociceptive effect of berberine in the rat formalin test
Berberine is an isoquinoline alkaloid naturally produced by several types of plants. Berberine has extensive pharmacological effects, such as anti-diabetic, anti-inflammatory, and ...
Berberine at sub-inhibitory concentration inhibits biofilm dispersal in Staphylococcus aureus
Berberine at sub-inhibitory concentration inhibits biofilm dispersal in Staphylococcus aureus
Staphylococcus aureus
is a major human pathogen, which has multiple drug resistance and can cause serious infections. Recent studies have s...
Antibiofilm activity of berberine inhibition Staphylococcus aureus
Antibiofilm activity of berberine inhibition Staphylococcus aureus
Abstract
Berberine, a naturally occurring isoquinoline alkaloid, has demonstrated strong antibiofilm properties against
Staphyl...
Berberine enhances cisplatin efficacy in ehrlich ascites carcinoma via modulation of apoptotic pathway and efferocytosis
Berberine enhances cisplatin efficacy in ehrlich ascites carcinoma via modulation of apoptotic pathway and efferocytosis
Abstract
Berberine, a bio-alkaloid from medicinal plants, shows therapeutic potential against various ailments, including cancer. This study evaluated berberine’s...
Exploring the Mechanism of Action of Berberine on Arrhythmia After Myocardial Infarction: A Network Pharmacology, Molecular Docking, and Cellular Experimental Study
Exploring the Mechanism of Action of Berberine on Arrhythmia After Myocardial Infarction: A Network Pharmacology, Molecular Docking, and Cellular Experimental Study
Background:
Arrhythmia after myocardial infarction, a common disease, has a high incidence and lethality in clinical practice, which seriously affects patients’...
Prostaglandin J2 causes dedifferentiation via PPAR‐gamma‐dependent pathway, but not COX‐2 expression in articular chondrocyte.
Prostaglandin J2 causes dedifferentiation via PPAR‐gamma‐dependent pathway, but not COX‐2 expression in articular chondrocyte.
The peroxisome proliferator‐activated receptors(PPARs) represent a family of nuclear receprtor ligand activated transcription factors that have been implicated in maintenance of li...

